Menlo Therapeutics Closes in on IPO
Menlo Therapeutics plans on pricing its more than 5 million shares in a range that results in an initial public offering valued up to more than $104 million.
All Work
Chris Lange
Are Synchrony Financial’s Q4 Results Good Enough?
Synchrony Financial reported better-than-expected fiscal fourth-quarter financial results before the markets opened on Friday.
American Express Slips Despite Solid Earnings Beat
American Express Co. (NYSE: AXP) reported its most recent quarterly results after the markets closed on Thursday. The company said that it had $1.58 in earnings per share (EPS) and $8.84 billion in revenue,…
Thursday’s Biggest Winners and Losers in the S&P 500
Thursday was a down day on Wall Street. After what was an incredible Wednesday, markets took a step back. A potential government shutdown could be contributing to this decline but a shutdown would only…
What Apple’s Next Update Will Mean for iPhone Batteries
Apple has been under fire recently concerning “Batterygate” and the fact that it might have misled its users.
What to Expect When American Express Reports After the Close
American Express is scheduled to release its most recent quarterly results after the markets close on Thursday.
Investors Cheer BeiGene’s Secondary Offering
BeiGene saw its shares make a handy gain on Thursday after the company announced that it would be conducting a secondary offering.
Morgan Stanley Boasts ‘Strong Momentum’ After Q4 Earnings Beat
Morgan Stanley reported better-than-expected fourth-quarter financial results before the markets opened on Thursday.
Wednesday’s Biggest Winners and Losers in the S&P 500
Wednesday was an incredible day for the U.S. markets. Once again all three of the major averages hit all-time highs. Although we are only about two weeks into the new year, this is easily…
What to Look For in IBM Earnings
IBM is scheduled to release its most recent quarterly results after the markets close on Thursday.
Merrill Lynch’s Bull/Bear Argument for Apple in 2018
Apple saw an incredible return in 2017, and the iPhone giant looks to be on track for another incredible year, according to one analyst.
Exelixis Slides Despite Positive Late-Stage Results
Shares of Exelixis slipped on Wednesday after the company reported results from its late-stage trial of cabozantinib for advanced hepatocellular carcinoma.
ARMO Announces Potential Pricing for IPO
ARMO BioSciences intends to price more than 6. million shares in a range that results in an initial public offering valued up to more than $122 million.
Why Juno Therapeutics Is Soaring
Juno Therapeutics saw its shares skyrocket early on Wednesday after reports that Celgene was in talks to acquire the company.
Goldman Sachs Looks Beyond Q4 Loss
Goldman Sachs reported a quarterly loss due to a one-time tax-related charge.
VICI Properties Gears Up for IPO
Hospitality and entertainment real estate holder VICI Properties has amended its filing with the SEC regarding its initial public offering.
Tuesday’s Biggest Winners and Losers in the S&P 500
Tuesday was a crazy day for the U.S. markets, while all three of the major averages hit all-time highs the S&P 500 and Nasdaq closed down on the day. Prior to the markets opening,…
What to Expect When Bank of America Reports Wednesday
Bank of America is scheduled to release its most recent quarterly results before the markets open on Wednesday morning.
Why Eiger BioPharma Shares Are Getting Crushed
Eiger BioPharmaceuticals watched its shares crater on Tuesday after the firm announced that its midstage study in pulmonary arterial hypertension did not meet its primary endpoint.
Merck Wins Big With Late-Stage Lung Cancer Drug Results
Merck saw its shares make a handy gain on Tuesday after it reported that a late-stage trial of Keytruda met its dual primary endpoints.